As a marker of minimal residual disease in B-cell acute lymphoblastic leukemia (B-ALL), CD58 has been reported in B-ALL at diagnosis and short-term follow-ups after standard chemotherapies. However, ...

In T cell cancers such as T cell lymphoblastic leukemia (TLL), this challenge arises from fratricide, CAR T cell self-destruction. 1–3 CAR T cells often share the same receptors as malignant T cells, ...

Twelve months after revaccination, antibody levels declined but remained significantly higher than baseline in patients with CLL.

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval ... DNA in addition to flow cytometry at least doubled early detection of MRD recurrences.